NEW YORK--(BUSINESS WIRE)--Sep 6, 2025--

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action lawsuit on behalf of purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between October 9, 2024 and July 10, 2025. Capricor is a clinical-stage biotechnology company.

For more information, submit a form , email attorney Phillip Kim, or give us a call at 866-767-3653.

The Allegations: Rosen Law Firm is Investigating the Allegations that Capricor Therapeutics, Inc. (NASDAQ: CAPR) Misled Investors Regarding its Business Operations.

According to the lawsuit, throughout the Class Period, defendants provided investors with material information concerning deramiocel, Capricor’s lead cell therapy candidate drug for the tre

See Full Page